Design, Synthesis, and Anticancer Activity of Novel Trimethoxyphenyl-Derived Chalcone-Benzimidazolium Salts
datasetposted on 20.11.2019, 12:34 by Jun-Li Yang, Yong-Hui Ma, Yan-Hua Li, Yi-Peng Zhang, Hong-Chang Tian, Yuan-Cheng Huang, Yan Li, Wen Chen, Li-Juan Yang
A series of novel trimethoxyphenyl-derived chalcone-benzimidazolium salts were synthesized. The biological properties of the compounds were screened in vitro against five different human tumor cell lines. The results suggest that the 5,6-dimethyl-benzimidazole or 2-methyl-benzimidazole ring as well as the 2-naphthylmethyl, 4-methylbenzyl, or 2-naphthylacyl substituent at position-3 of the benzimidazole ring was important to the cytotoxic activity. Notably, (E)-5,6-dimethyl-3-(naphthalen-2-ylmethyl)-1-(3-(4-(3-(3,4,5-trimethoxyphenyl)acryloyl)phenoxy)propyl)-1H-benzo[d]imidazol-3-ium bromide (7f) was more selective to HL-60, MCF-7, and SW-480 cell lines with IC50 values 8.0-, 11.1-, and 5.8-fold lower than DDP. Studies of the antitumor mechanism of action showed that compound 7f could induce cell-cycle G1 phase arrest and apoptosis in SMMC-7721 cells.
Read the peer-reviewed publication
compound 7 fnovel trimethoxyphenyl-derived chalcone-benzimidazolium saltsSW -480 cell linesSMMC -7721 cells2- methyl-benzimidazole ringcytotoxic activitycell-cycle G 1 phase arrestHL2- naphthylacyl substituenttumor cell linesDDPantitumor mechanism7 fNovel Trimethoxyphenyl-Derived Chalcone-Benzimidazolium Salts2- naphthylmethylposition -34- methylbenzylbenzimidazole ringICMCFAnticancer Activity